The SARS-CoV-2 specific CD4 and CD8 T-cell responses at four weeks after receiving the ChAdOx-1/ChAdOx-1 homologous vaccine were compared between COPD and healthy elderly groups. This evidence concerns the gene CD8A and chronic obstructive pulmonary disease.